94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Jason P. Appleton1,2
Lisa J. Woodhouse1Nikola Sprigg1,3
Joanna M. Wardlaw4
Philip M. Bath1,3* on behalf of the ENOS, RIGHT, and RIGHT-2 Investigators- 1Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, United Kingdom
- 2Stroke, University Hospitals Birmingham National Health Service Foundation Trust, Birmingham, United Kingdom
- 3Stroke, Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom
- 4Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
by Appleton, J. P., Woodhouse, L. J., Sprigg, N., Wardlaw, J. M., and Bath, P. M. (2020). Front. Neurol. 11:584038. doi: 10.3389/fneur.2020.584038
Joanna M. Wardlaw was not included as an author in the published article. The corrected Author Contributions and Funding statements appear below.
Author Contributions
JA performed the literature search, pooled analyses, statistical analysis and interpretation, manuscript drafting, and editing. LW performed pooling of databases, statistical interpretation, reviewed, and edited the manuscript. NS performed statistical interpretation, reviewed, and edited the manuscript. JW set up and co-ordinated all scan reading, including scan rating, training and data cleaning, reviewed and edited the manuscript. PB conceptualized the study, statistical interpretation, reviewed, and edited the manuscript, is corresponding author and has responsibility for submission. All authors contributed to the article and approved the submitted version.
Funding
There was no specific funding for the present study. ENOS was funded by the UK Medical Research Council (G0501797) and BUPA foundation. RIGHT was funded by Nottingham University Hospitals NHS Trust (R&D Pump Priming Competition) and by the Division of Stroke, University of Nottingham. RIGHT-2 was funded by the British Heart Foundation (CS/14/4/30972). JW declares funding from the Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) and the UK Dementia Research Institute which receives funding from the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: bleeding, glyceryl trinitrate, ischaemic stroke, reperfusion, thrombolysis, thrombectomy, meta-analysis
Citation: Appleton JP, Woodhouse LJ, Sprigg N, Wardlaw JM and Bath PM (2020) Corrigendum: Intracranial Bleeding After Reperfusion Therapy in Acute Ischaemic Stroke Patients Randomized to Glyceryl Trinitrate vs. Control: An Individual Patient Data Meta-Analysis. Front. Neurol. 11:625572. doi: 10.3389/fneur.2020.625572
Received: 03 November 2020; Accepted: 04 November 2020;
Published: 26 November 2020.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2020 Appleton, Woodhouse, Sprigg, Wardlaw and Bath. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Philip M. Bath, cGhpbGlwLmJhdGhAbm90dGluZ2hhbS5hYy51aw==